Search

Your search keyword '"Ouerhani, Slah"' showing total 170 results

Search Constraints

Start Over You searched for: Author "Ouerhani, Slah" Remove constraint Author: "Ouerhani, Slah"
170 results on '"Ouerhani, Slah"'

Search Results

12. Correlation between E‐cadherin/β‐catenin, Vimentin expression, clinicopathologic features and drug resistance prediction in naïve prostate cancer: A molecular and clinical study

15. Next-generation sequencing of Tunisian Leigh syndrome patients reveals novel variations: impact for diagnosis and treatment

16. An insight into the diagnostic and prognostic value of HOX A13 ’s expression in non‐muscle invasive bladder cancer

24. Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort

31. Development of a Custom NGS Panel for the Determination of Bladder Cancer Risk

35. Evaluating prognostic utility of preoperative Neutrophil to Lymphocyte Ratio and hsa-let-7g/c up-regulation in patients with urinary bladder cancer

36. miR-143 expression profiles in urinary bladder cancer: correlation with clinical and epidemiological parameters

37. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development

39. Evaluating prognostic utility of preoperative Neutrophil to Lymphocyte Ratio and hsa-let-7g/c up-regulation in patients with urinary bladder cancer.

41. Association of genetic variation inIKZF1, ARID5B, CDKN2A, andCEBPEwith the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence

43. Association of genetic variation in IKZF1, ARID5B, CDKN2A , and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.

44. A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer

47. In Vivo Prevention of Bladder Urotoxicity

48. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development

49. Expression of WISP3 and RhoC Genes at mRNA and Protein Levels in Inflammatory and Noninflammatory Breast Cancer in Tunisian Patients

50. Abstract B92: P38 MAPK activation is critical for FGFR3‐induced cell transformation in human bladder carcinoma

Catalog

Books, media, physical & digital resources